As of 2025-07-20, the Relative Valuation of Medifron DBT Co Ltd (065650.KQ) is (46,092.85) KRW. This relative valuation is based on P/E multiples. With the latest stock price at 5,210.00 KRW, the upside of Medifron DBT Co Ltd based on Relative Valuation is -984.7%.
The range of the Relative Valuation is (43,125.95) - (48,318.02) KRW.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 9.3x | 8.6x |
| Forward P/E multiples | 8.1x - 9.1x | 8.8x |
| Fair Price | (43,125.95) - (48,318.02) | (46,092.85) |
| Upside | -927.8% - -1027.4% | -984.7% |
| Date | P/E |
| 2025-06-27 | -0.68 |
| 2025-06-26 | -0.52 |
| 2025-05-29 | -0.35 |
| 2025-05-28 | -0.35 |
| 2025-05-27 | -0.32 |
| 2025-05-26 | -0.32 |
| 2025-05-23 | -0.32 |
| 2025-05-22 | -0.33 |
| 2025-05-21 | -0.34 |
| 2025-05-20 | -0.33 |
| 2025-05-19 | -0.33 |
| 2025-05-16 | -0.33 |
| 2025-05-15 | -0.33 |
| 2025-05-14 | -0.32 |
| 2025-05-13 | -0.33 |
| 2025-05-12 | -0.33 |
| 2025-05-09 | -0.32 |
| 2025-05-08 | -0.33 |
| 2025-05-07 | -0.33 |
| 2025-05-02 | -0.32 |
| 2025-04-30 | -0.33 |
| 2025-04-29 | -0.34 |
| 2025-04-28 | -0.35 |
| 2025-04-25 | -0.32 |
| 2025-04-24 | -0.32 |
| 2025-04-23 | -0.32 |
| 2025-04-22 | -0.31 |
| 2025-04-21 | -0.32 |
| 2025-04-18 | -0.33 |
| 2025-04-17 | -0.32 |
| 2025-04-16 | -0.31 |
| 2025-04-15 | -0.32 |
| 2025-04-14 | -0.32 |
| 2025-04-11 | -0.32 |
| 2025-04-10 | -0.31 |
| 2025-04-09 | -0.28 |
| 2025-04-08 | -0.31 |
| 2025-04-07 | -0.29 |
| 2025-04-04 | -0.30 |
| 2025-04-03 | -0.30 |
| 2025-04-02 | -0.31 |
| 2025-04-01 | -0.31 |
| 2025-03-31 | -0.31 |